Prognostic value of T-cell receptor γ rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas

Leukemia and Lymphoma

Volumn 49, Issue 2, 2008, Pages 237-246

  Schützinger, Christian ^a   Esterbauer, Harald ^a   Hron, Gregor ^a   Skrabs, Cathrin ^a   Uffmann, Martin ^a   Raderer, Markus ^a   Hauswirth, Alexander ^a   Mannhalter, Christine ^a   Dieckmann, Karin ^a   Wagner, Oswald ^a   Formanek, Michael ^a   Stift, Anton ^a   Friedl, Josef ^a   Gaiger, Alexander ^a   Chott, Andreas ^a   Jäger, Ulrich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Molecular staging; Peripheral T cell lymphoma; Prognostic value; TCR rearrangement

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD; BONE MARROW; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR DYNAMICS; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE RECEPTOR GENE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELLS; BONE MARROW; FEMALE; GENE REARRANGEMENT; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38849148273     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701784409     Document Type: Article

References (36)

1. Armitage, J. O., Greer, J. P., Levine, A. M., Weisenburger, D. D., Formenti, S. C. and Bast, M. (1989) Peripheral T-cell lymphoma. Cancer, 63, pp. 158-163.
2. Armitage, J. O., Vose, J. M. and Weisenburger, D. D. (2004) Towards understanding the peripheral T-cell lymphomas. Ann Oncol, 15, pp. 1447-1449.
3. Jaffe, E. S. and Ralfkiaer, E. (2001) Angioimmunoblastic lymphoma. pp 225-226, and Jaffe ES. Histological classification of mature T-cell and NK-cell neoplasms, pp 190-94. World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of the Haemaopoietic and Lymphoid Tisues, IARC Press, Lyon
4. Rüdiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J. and MacLennan, K. A. (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol, 13, pp. 140-149.
5. Jaffe, E. S. (2006) Pathobiology of peripheral T-cell lymphomas. Hematol Am Soc Hematol Educ Program, 1, pp. 317-322.
6. Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J. and Haioun, C. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, pp. 76-82.
7. Coiffier, B., Brousse, N., Peuchmaur, M., Berger, F., Gisselbrecht, C. and Bryon, P. A. (1990) Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol, 1, pp. 45-50.
8. Savage, K. J., Chhanabhai, M., Gascoyne, R. D. and Connors, J. M. (2004) Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol, 15, pp. 1467-1475.
9. Kurzrock, R. and Ravandi, F. (2006) Purine analogues in advanced T-cell lymphoid malignancies. Semin Hematol, 43:2, pp. S27-S34.
10. Ramasamy, K., Lim, Z., Pagliuca, A., Salisbury, J. R., Mufti, G. J. and Devereux, S. (2006) Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica, 91:8, p. ECR44.
11. Hotta, T. (2005) Treatment of T-Cell lymphoma. Hematology, 10, pp. 193-196.
12. Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F. B., Younes, A. and Andersson, B. (2001) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol, 19, pp. 3766-3770.
13. Corradini, P., Tarella, C., Zallio, F., Dodero, A., Zanni, M. and Valagussa, P. (2006) Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia, 20, pp. 1533-1538.
14. Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A. P. and Repp, R. (2004) A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood, 103, pp. 2920-2924.
15. Rodig, S. J., Abramson, J. S., Pinkus, G. S., Treon, S. P., Dorfman, D. M. and Dong, H. Y. (2006) Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res, 12, pp. 7174-7179.
16. Talpur, R., Apisarnthanarax, N., Ward, S. and Duvic, M. (2002) Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK). Leuk Lymphoma, 43, pp. 121-126.
17. Sonnen, R., Schmidt, W. P., Muller-Hermelink, H. K. and Schmitz, N. (2005) The international prognostic index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol, 129, pp. 366-372.
18. Escalon, M. P., Liu, N. S., Yang, Y., Hess, M., Walker, P. L. and Smith, T. L. (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma. Cancer, 103, pp. 2091-2098.
19. Gallamini, A., Stelitano, C., Calvi, R., Bellei, M., Mattei, D. and Vitolo, U. (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood, 103, pp. 2474-2479.
20. Park, P. P., Ryoo, B. Y., Lee, J. H., Kwon, H. C., Yang, S. H. and Kang, H. J. (2007) Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma, 48, pp. 716-722.
21. Ishida, T., Inagaki, H., Utsunomiya, A., Takatsuka, Y., Komatsu, H. and Iida, S. (2004) CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res, 10, pp. 5494-5500.
22. Tsuchiya, T., Ohshima, K., Karube, K., Yamaguchi, T., Suefuji, H. and Hamasaki, M. (2004) Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: Comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood, 103, pp. 236-241.
23. Juarez, T., Isenhath, S. N., Polissar, N. L., Sabath, D. E., Wood, B. and Hanke, D. (2005) Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods. Arch Dermatol, 141, pp. 1107-1113.
24. Tan, B. T., Warnke, R. A. and Arber, D. A. (2006) The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: A comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn, 8, pp. 466-475.
25. Födinger, M., Buchmayer, H., Schwarzinger, I., Simonitsch, I., Winkler, K. and Jager, U. (1996) Multiplex PCR for rapid detection of T-cell receptor-gamma chain gene rearrangements in patients with lymphoproliferative diseases. Br J Haematol, 94, pp. 136-139.
26. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I. and Connors, J. M. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol, 17, p. 1244.
27. van Dongen, J. J., Langerak, A. W., Bruggemann, M., Evans, P. A., Hummel, M. and Lavender, F. L. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 17, pp. 2257-2317.
28. Trainor, K. J., Brisco, M. J., Wan, J. H., Neoh, S., Grist, S. and Morley, A. A. (1991) Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood, 78, pp. 192-196.
29. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53, pp. 457-481.
30. Stablein, D. M., Carter Jr, W. H. and Novak, J. W. (1981) Analysis of survival data with nonproportional hazard functions. Control Clin Trials, 2, pp. 149-159.
31. Reiser, M., Josting, A., Soltani, M., Staib, P., Salzberger, B. and Diehl, V. (2002) T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma, 43, pp. 805-811.
32. Langerak, A. W., Molina, T. J., Lavender, F. L., Pearson, D., Flohr, T. and Sambade, C. (2007) Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: Usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia, 21, pp. 222-229.
33. van Krieken, J. H., Langerak, A. W., Macintyre, E. A., Kneba, M., Hodges, E. and Sanz, R. G. (2007) Improved reliability of lymphoma diagnostics via PCR-based clonality testing: Report of the BIOMED-2 concerted action BHM4-CT98-3936. Leukemia, 21, pp. 201-206.
34. Droese, J., Langerak, A. W., Groenen, P. J., Bruggemann, M., Neumann, P. and Wolvers-Tettero, I. L. (2004) Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies. Leukemia, 18, pp. 1531-1538.
35. Sandberg, Y., Verhaaf, B., van Gastel-Mol, E. J., Wolvers-Tettero, I. L., de Vos, J. and Macleod, R. A. (2007) Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes. Leukemia, 21, pp. 230-237.
36. Bishu, S., Quigley, J. M., Schmitz, J., Bishu, S. R., Stemm, R. A. and Olsasky, S. M. (2007) F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma, 48, pp. 1531-1538.